2Theresa L, Michele L, Kenneth R, et al. Emergence of vancomycin resistance in Staphylococcus aureus[J]. N Engl J Med, 1999,340:493.
3May J, Shannon K, King A, et al. Glycopeptide tolerance in Staphylococcus aureus[J]. J Antimicrob Chemother, 1998,42(2):189.
4Bierbaum G, Fuchs K, Lenz W, et al. Presence of Staphylococcus aureus with reduced susceptibility to vacomycin in Germany [J]. Eur J Clin Microbiol Infect Dis, 1999,18(10):691.
5Marchese A, Balistreri G, Tonoli E, et al. Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital[J]. J Clin Microbiol, 2000,38(2):866.
6Krzysatof S, Alexander T. Inhibition of cell wall and autolysis by vancomycin in highly vancomycin resistant mutant of Staphylococcus aureus[J]. Bacteriology, 1997,179(8) :2557.
7Beatriz M, Susan BV, Boudewijn LM, et al. Increased production of penicillin-binding protein 2, increased detection of other penicillinbindign proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus [J]. Antimicrob Angents Chemother, 1997,41 (8): 1788.
8Wong SS, Ng TK, Yan WC, et al. Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin [J]. Daign Microbiol Infect Dis,2000,3(4):261.
9Tenover FC, Lancaster MV, Hill BC. Characterization of Staphylococcus aureus with reduced susceptibilities to vancomycin and other glycopeptides[J]. J Clin Microbiol, 1998,36(4): 1020.
